Vancomycin Dosing Practices, Trough Concentrations, and Predicted Area Under the Curve in Children With Suspected...

Area of Science:

• Pediatric Infectious Diseases
• Pharmacokinetics and Pharmacodynamics
• Antimicrobial Stewardship

Background:

• Current pediatric guidelines recommend empiric vancomycin dosing at 60 mg/kg/day.
• Higher target trough concentrations (15-20 mcg/mL) are advised for invasive infections.
• Optimizing vancomycin therapy is crucial for effective treatment and minimizing resistance.

Purpose of the Study:

• To evaluate the relationship between vancomycin dosing, achieved trough concentrations, and predicted area under the curve (AUC).
• To assess the effectiveness of current dosing strategies in pediatric patients with invasive staphylococcal infections.
• To inform future vancomycin dosing recommendations in pediatric populations.

Main Methods:

• Retrospective review of pediatric patients receiving vancomycin.
• Analysis of vancomycin dose, serum trough concentrations, and calculated AUC.
• Correlation of pharmacokinetic parameters with clinical outcomes in invasive staphylococcal infections.

Main Results:

• The study identified variability in the dose-trough relationship.
• Predicted AUC values were analyzed in relation to achieved trough concentrations.
• Initial findings suggest a need for individualized vancomycin dosing adjustments.

Conclusions:

• Current vancomycin dosing may require optimization to achieve target concentrations in pediatric patients.
• Further research is warranted to refine dosing strategies for invasive staphylococcal infections.
• Individualized pharmacokinetic monitoring can enhance vancomycin efficacy in children.